|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A01N 43/58 |
| (11) | Patento numeris | 3243385 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17173914.7 |
| Europos patento paraiškos padavimo data | 2012-02-23 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-11-15 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-01-13 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201161446551 P | 2011-02-25 | US |
| (72) |
ANAND, Rajan, US
APGAR, James, M., US
BIFTU, Tesfaye, US
CHEN, Ping, US
CHU, Lin, US
COLANDREA, Vincent, J., US
DONG, Guizhen, US
DROPINSKI, James, F., US
FENG, Danqing, US
HICKS, Jacqueline, D., US
JIANG, Jinlong, US
KIM, Alexander, J., US
LEAVITT, Kenneth, J., US
LI, Bing, US
QIAN, Xiaoxia, US
SEBHAT, Iyassu, US
WEI, Lan, US
WILKENING, Robert, R., US
WU, Zhicai, US
|
| (73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
|
| (54) | NOVEL CYCLIC AZABENZIMIDAZOLE DERIVATIVES USEFUL AS ANTI-DIABETIC AGENTS |
| NOVEL CYCLIC AZABENZIMIDAZOLE DERIVATIVES USEFUL AS ANTI-DIABETIC AGENTS |